Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 159 participants.

Also called NCT01728220

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 159 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01728220
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01728220. Randomized; quadruple masking; primary purpose treatment. Start 2012-12 (registry gives no type); primary completion 2014-06 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
Condition
Chronic Obstructive Pulmonary Disease
Intervention (Combination product)
Inhaled NO delivered via INOpulse DS-C Device
Intervention (Combination product)
Placebo delivered via INOpulse DS-C Device
Lead sponsor
Bellerophon Pulse Technologies (class: industry)

Record details

Record id
cardio:ct-nct01728220
Content hash
8135a840ee01dfcb31de94193687a50308d70a69afb5dcbb5c72f6d3e0572074